DK1399186T3 - Lægemiddel til behandling af tumorer og disses metastaser under anvendelse af et bindemolekyle mod knogle-sialoprotein - Google Patents
Lægemiddel til behandling af tumorer og disses metastaser under anvendelse af et bindemolekyle mod knogle-sialoproteinInfo
- Publication number
- DK1399186T3 DK1399186T3 DK02748771.9T DK02748771T DK1399186T3 DK 1399186 T3 DK1399186 T3 DK 1399186T3 DK 02748771 T DK02748771 T DK 02748771T DK 1399186 T3 DK1399186 T3 DK 1399186T3
- Authority
- DK
- Denmark
- Prior art keywords
- bone
- metastases
- drug
- molecule
- treating tumors
- Prior art date
Links
- 102000016921 Integrin-Binding Sialoprotein Human genes 0.000 title abstract 2
- 108010028750 Integrin-Binding Sialoprotein Proteins 0.000 title abstract 2
- 206010027476 Metastases Diseases 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 210000000988 bone and bone Anatomy 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Toxicology (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Reproductive Health (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01114388 | 2001-06-13 | ||
| DE10128639 | 2001-06-15 | ||
| PCT/EP2002/006456 WO2002100899A2 (de) | 2001-06-13 | 2002-06-12 | Arzneimittel zur behandlung von tumoren und deren metastasen unter verwendung eines bindemoleküls gegen das bone-sialoprotein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1399186T3 true DK1399186T3 (da) | 2010-03-29 |
Family
ID=26009516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02748771.9T DK1399186T3 (da) | 2001-06-13 | 2002-06-12 | Lægemiddel til behandling af tumorer og disses metastaser under anvendelse af et bindemolekyle mod knogle-sialoprotein |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7825219B2 (da) |
| EP (1) | EP1399186B1 (da) |
| JP (1) | JP4570355B2 (da) |
| AT (1) | ATE448796T1 (da) |
| AU (1) | AU2002319223A1 (da) |
| DE (1) | DE50214008D1 (da) |
| DK (1) | DK1399186T3 (da) |
| ES (1) | ES2336770T3 (da) |
| PT (1) | PT1399186E (da) |
| WO (1) | WO2002100899A2 (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1514929A1 (en) * | 2003-09-12 | 2005-03-16 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Antisense oligonucleotides for prevention of metastasis formation of cancer cells |
| US8282943B2 (en) | 2005-05-31 | 2012-10-09 | Ralf Jochem | Therapeutic composition for use in the prevention and treatment of bone metastases |
| WO2007038397A2 (en) * | 2005-09-26 | 2007-04-05 | Novartis Ag | Molecular markers associated with bone metastasis |
| RU2011111725A (ru) * | 2008-08-29 | 2012-10-10 | Симфоген А/С (Dk) | Способ клонирования антител птиц |
| JP6675383B2 (ja) * | 2014-08-19 | 2020-04-01 | イムーンダイアグノスティック・アー・ゲー | 慢性腎疾患の治療のための医薬および装置 |
| EP4373522A1 (en) * | 2021-07-20 | 2024-05-29 | William Marsh Rice University | Engineered compositions for bone-targeted therapy |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4853219A (en) * | 1987-08-06 | 1989-08-01 | President And Fellows Of Harvard College | Antibodies to angiogenin: immunotherapeutic agents |
| US5601819A (en) * | 1988-08-11 | 1997-02-11 | The General Hospital Corporation | Bispecific antibodies for selective immune regulation and for selective immune cell binding |
| US5340934A (en) * | 1989-11-03 | 1994-08-23 | The United States Of Americas As Represented By The Secretary Of Health & Human Services | CDNA sequences of human bone matrix proteins |
| EP0940468A1 (en) * | 1991-06-14 | 1999-09-08 | Genentech, Inc. | Humanized antibody variable domain |
| WO2000062065A1 (en) * | 1999-04-09 | 2000-10-19 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, The National Institutes Of Health | Complex formed by n-linked glycoproteins (siblings) and factor h |
-
2002
- 2002-06-12 US US10/480,465 patent/US7825219B2/en not_active Expired - Fee Related
- 2002-06-12 EP EP02748771A patent/EP1399186B1/de not_active Expired - Lifetime
- 2002-06-12 AU AU2002319223A patent/AU2002319223A1/en not_active Abandoned
- 2002-06-12 ES ES02748771T patent/ES2336770T3/es not_active Expired - Lifetime
- 2002-06-12 WO PCT/EP2002/006456 patent/WO2002100899A2/de active Application Filing
- 2002-06-12 AT AT02748771T patent/ATE448796T1/de active
- 2002-06-12 PT PT02748771T patent/PT1399186E/pt unknown
- 2002-06-12 DE DE50214008T patent/DE50214008D1/de not_active Expired - Lifetime
- 2002-06-12 DK DK02748771.9T patent/DK1399186T3/da active
- 2002-06-12 JP JP2003503665A patent/JP4570355B2/ja not_active Expired - Lifetime
-
2010
- 2010-10-08 US US12/901,399 patent/US8808691B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU2002319223A1 (en) | 2002-12-23 |
| WO2002100899A3 (de) | 2003-12-18 |
| US20110091379A1 (en) | 2011-04-21 |
| US8808691B2 (en) | 2014-08-19 |
| DE50214008D1 (de) | 2009-12-31 |
| EP1399186A2 (de) | 2004-03-24 |
| ATE448796T1 (de) | 2009-12-15 |
| US20050069547A1 (en) | 2005-03-31 |
| ES2336770T3 (es) | 2010-04-16 |
| PT1399186E (pt) | 2010-02-23 |
| JP4570355B2 (ja) | 2010-10-27 |
| US7825219B2 (en) | 2010-11-02 |
| JP2005506959A (ja) | 2005-03-10 |
| EP1399186B1 (de) | 2009-11-18 |
| WO2002100899A2 (de) | 2002-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE457166T1 (de) | Orale zusammensetzungen zur behandlung von diabetes | |
| CY1109661T1 (el) | 5-cnac ως παραγοντας για χορηγηση απο το στομα τμηματων παραθορμονης | |
| CY1106386T1 (el) | Υποκατεστημενα παραγωγα 3-πυρρολιδιν-ινδολης | |
| CY1117387T1 (el) | ΜΟΝΟΚΛΩΝΙΚΑ ΑΝΤΙΣΩΜΑΤΑ Ν-11 ΔΙΑΣΠΑΣΜΕΝΟΥ β-ΑΜΥΛΟΕΙΔΟΥΣ, ΣΥΝΘΕΣΕΙΣ, ΜΕΘΟΔΟΙ ΚΑΙ ΧΡΗΣΕΙΣ | |
| TR200102707T2 (tr) | AĞrì hafifletme, kemik kanseri terapisi ve kemik yzeyinin saĞlìklì tutulmasì iin kirelenmiç hedef dokulara ynelik radyum-223 hazìrlanmasì ve kullanìmì. | |
| CY1108661T1 (el) | Αναστολεις ρ38 και μεθοδοι χρησης αυτων | |
| CY1108436T1 (el) | Χορηγηση καψαϊκινοειδων | |
| BRPI0309665B8 (pt) | método para analisar uma preparação de alfagalactosidase a | |
| MY151032A (en) | Treatment of tnf? related disorders | |
| IS7431A (is) | Samrunaefnasambönd lyfja eða frumudrepandi efna og líffræðilega virkra peptíða | |
| BRPI0415858A (pt) | compostos de medicamentos terapêuticos modificados por tocoferol | |
| CY1108384T1 (el) | Διαδερμικη δοσολογια βουπρενορφινης για αναλγησια | |
| MXPA05006670A (es) | Administracion de capsaicinoides. | |
| ATE548388T1 (de) | An den interleukin-4-rezeptor bindende antikörper | |
| ATE389411T1 (de) | Strontium verbindung zur behandlung von sub- dermalem weichteilschmerz | |
| CY1109361T1 (el) | Υποκατεστημενες 4-αμινοκυκλοεξανολες | |
| DE60239707D1 (de) | Antimikrobielle kationische peptide und diese enthaltende formulierungen | |
| WO2002041837A3 (en) | Treatment of mucositis | |
| CY1109045T1 (el) | Ρετινοειδη για τη θεραπεια του εμφυσηματος | |
| AR047229A1 (es) | Administracion de conjugados polimericos de peptidos y proteinas terapeuticos por medio de microproyecciones revestidas | |
| CY1113116T1 (el) | Υποκατεστημενες 4-αμινοκυκλοεξανολες | |
| CY1112184T1 (el) | Πυριδοξαμινη για χρηση στην αγωγη της διαβητικης nεφροπαθειας στο διαβητη τυπου ii | |
| CY1109013T1 (el) | Νεα 4,4΄-διθειοδις-(3-αμινοβουτανιο-1-σουλφονικα) παραγωγα και συνθεσεις που τα περιεχουν | |
| CY1113894T1 (el) | Φαρμακευτικη συνθεση που περιλαμβανει ροφλουμιλαστη και λεβοκετιριζινη | |
| CY1107231T1 (el) | Υποκατεστημενα παραγωγα 4-αμινοκυκλοεξανολης |